Polymeric Biomaterials Industry Growth Outlook: 15.9% CAGR and $125.13 Billion by 2029

Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.

What Is the Long-Term Growth Forecast for the Polymeric Biomaterials Market Size 2025?
The market size for polymeric biomaterials has experienced significant growth lately. Its size is projected to increase from $59.69 billion in 2024 to $69.32 billion in 2025, signaling a compound annual growth rate (CAGR) of 16.1%. Factors influencing the growth during the historical period included a surge in demand for medical implants, improved biocompatibility, advancements in tissue engineering, a rise in orthopedic surgeries, as well as an increase in drug delivery systems.

What CAGR is Forecasted for the Polymeric Biomaterials Market Through 2029?
The market for polymeric biomaterials is projected to experience a swift rise in the upcoming years. It's anticipated to reach a valuation of $125.13 billion by 2029, rising at a compound annual growth rate (CAGR) of 15.9%. The expected growth during the predicted period can be credited to factors such as regenerative medicine, personalized medicine, environmental concerns, 3D printing, chronic disease management, and minimally invasive surgery. Significant trends within the forecasted period encompass progress in polymer chemistry, breakthroughs in biomedical engineering, regulatory approvals, incorporation of technology, and academic investigations.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/polymeric-biomaterials-global-market-report

What Are the Critical Factors Driving Polymeric Biomaterials Market Development?
The increasing incidence of chronic ailments is predicted to spur the expansion of the polymeric biomaterials market. Chronic conditions refer to persistent diseases that typically progress at a gradual pace and last an extended period, often throughout a person's lifetime. There are multiple reasons contributing to the rise in chronic diseases, including an aging demographic, lifestyle choices, financial strain, health care needs and public health issues. Polymeric biomaterials play a crucial role in the treatment of chronic diseases by providing innovative ways to increase the effectiveness of healthcare and improve the overall quality of life for those living with such conditions. They are further utilized in creating a range of medical devices and implants such as stents, catheters, and joint substitutes, which are crucial for addressing chronic diseases that need surgical procedures. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in September 2023 that out of 41 million annual deaths worldwide, 74% or approximately 30.3 million are due to chronic illness. This figure includes 17.9 million deaths from heart diseases, 9.3 million from cancer, 4.1 million from persistent respiratory diseases, and 2.0 million from diabetes. Consequently, the increasing emergence of chronic ailments fuels the growth of the polymeric biomaterials market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15898&type=smp

How Does the Polymeric Biomaterials Market Break Down Across Major Segments?
The polymeric biomaterials market covered in this report is segmented -

1) By Product: Polylactic Acid, Polyglycolic Acid, Polyurethanes, Polytetrafluoroethylene, ket*one, Polydioxanone, Other Products
2) By Application: Cardiovascular, Dental, Orthopedic, Plastic Surgery, Neurology, Other Applications
3) By End-User: Hospitals, Clinics, Other End-users

Subsegments:
1) By Polylactic Acid (PLA): PLA-Based Scaffolds, PLA-Based Sutures And Stents
2) By Polyglycolic Acid (PGA): PGA-Based Sutures, PGA-Based Scaffolds
3) By Polyurethanes: Polyurethane-Based Wound Dressings, Polyurethane-Based Implants
4) By Polytetrafluoroethylene (PTFE): PTFE-Based Vascular Grafts, PTFE-Based Membranes
5) By ket*one (PAEK): PAEK-Based Implants, PAEK-Based Prosthetics
6) By Polydioxanone (PDO): PDO-Based Sutures, PDO-Based Drug Delivery Systems
7) By Other Products: Biodegradable Polymers, Natural Polymers

What Are the Major Trends Transforming the Polymeric Biomaterials Industry?
Significant players in the polymeric biomaterials market are concentrating on the creation of novel solutions, like 3D printable biomaterials, to achieve a competitive edge. These printable biomaterials pertain to a category of substances that can be used in 3D printing methods to construct devices and structures for medical use. For example, Evonik Industries AG, a chemical firm based in Germany, unleashed a new osteoconductive PEEK filament called the VESTAKEEP iC4800 3DF in March 2022. This product enhances the fusion between implants and bone. It is a superior polymeric biomaterial created for use in 3D-printed medical implants, as it encourages bone growth due to its biocompatible nature and unique properties. The VESTAKEEP iC4800 3DF is a groundbreaking osteoconductive PEEK filament, enabling the 3D printing of customized implants which boost bone fusion. This fast-tracks the healing process and improves implant integration, prompts speedy patient recovery, allows for the crafting of bespoke implant designs, and broadens the range of Evonik's 3D printable biomaterials intended for medical purposes.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15898&type=smp

Which Players Are Driving Innovation in the Polymeric Biomaterials Market?
Major companies operating in the polymeric biomaterials market are BASF SE, 3M Company, Medtronic plc, Toray Industries Inc., Evonik Industries AG, Covestro AG, Stryker Corporation, Solvay SA, DuPont Biomaterials, Arkema Group, Mitsubishi Chemical Holdings Inc., Celanese Corporation, Royal DSM, TEIJIN Limited, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Huafon Group, W. L. Gore & Associates Inc., Corbion NV, Integra LifeSciences Holdings Corporation, Victrex plc, Collagen Matrix, Berkeley Advanced Biomaterials, Bezwada Biomedical LLC, Covation Biomaterials, Starch Medical Inc.

Which Regions Are Driving Global Polymeric Biomaterials Market Expansion?
North America was the largest region in the polymeric biomaterials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymeric biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.